Form 4: GoodRx Holdings Executive Romin Nabiey Reports Stock Transactions
SEC Form 4 Filing
Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the vesting and subsequent disposal of Class A Common Stock to cover tax obligations.
Summary
- On January 15, 2025, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., reported transactions involving Class A Common Stock.
- 2,606 shares vested from restricted stock units and were subsequently disposed of.
- An additional 1,071 shares were disposed of at a price of $4.15.
- Following these transactions, Nabiey directly owns 91,979 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent a small portion of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 04/15/2021 | 19% of restricted stock units vested. |
| 01/15/2025 | Date of stock transactions: vesting of 2,606 restricted stock units and disposal of 1,071 shares at $4.15. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.